a b s t r a c tThe strain Bacillus amyloliquefaciens CCMI 1051 used in this study has been isolated in our laboratory from healthy Quercus suber in the south of Portugal and shows high levels of antagonistic properties against filamentous fungi that attack forest products industry due to the production of bioactive peptides.A combined use of LC-ESI-MS and antifungal tests allowed a rapid identification of lipopeptides as active compounds produced. Applying autobiographic methods it was possible to obtain active compounds. LC-ESI-MS, a powerful tool for rapid identification, indicates the presence of lipopeptides and MS 2 electrospray ionization showed the partial sequence Tyr-Asn-Pro-Glu in the peptidic portion of some compounds produced. The association of mass spectrometry and chromatography, used in parallel with antifungal tests proved to be an efficient approach for the characterization of active lipopeptides without the need of previous total isolation. This methodology can be employed for screening and optimization the production of antifungal iturinic lipopeptides, showing a great potential for future application.
Aims: The aim of this study was to evaluate the influence of environmental conditions on the antifungal activity of the Bacillus sp. CCMI 1053 cultures.
Methods and Results: The electrospray ionization mass spectra (ESI‐MS) analysis was used to detect the active peptides produced by Bacillus amyloliquefaciens CCMI 1051 cultures in a glucose‐containing medium to which four different nitrogen sources were added. The cultures produced different patterns of Bacillus sporulation and distinct antifungal activity of the cell‐free culture broths.
Conclusions: The highest sporulation obtained corresponds to higher antifungal activity when it is formed after 3 days of microbial growth. The antifungal activity against Trichoderma harzianum CCMI 783 is more influenced by the concentration on the nitrogen source than the culture time of incubation. The association of nitrogen concentration and the time of incubation is particularly relevant in the expression of the antifungal activity.
Significance and Impact of the Study: The present findings allow the reduction of the use of chemical pesticides and to limit some plant diseases. The association of the nitrogen source and the time of incubation is a novelty, which would improve the production of secondary metabolites. Both economical and environmental benefits arise from the study.
Bacillus amyloliquefaciens CCMI 1051 displays antifungal activity against surface contaminant fungi, blue stain fungi and phytopathogenic fungi. The antifungal potential of B. amyloliquefaciens CCMI 1051 is based on the production of metabolites with antifungal activity. The activity was revealed both in the exponential growth phase and in the stationary phase, being associated both to microbial growth and to secondary metabolism.
Amanita ponderosa is a specie of wild edible mushrooms growing spontaneously in some Mediterranean microclimates, namely in Alentejo and Andaluzia, in the Iberian Peninsula. The nutritional values of these fungi make them highly exportable. Due to the wide diversity of mushrooms in nature, it is essential to differentiate and to identify the various edible species. RAPD markers have been used as a valuable tool to distinguish the different genotypes, although this method has not yet been used to Amanita ponderosa. Two methods were used to establish different genetic fingerprinting patterns of edible mushrooms. Samples of Amanita ponderosa were collected in six different regions of the southwest of the Iberian Peninsula and compared by RAPD-PCR and MSP-PCR. Additionally, to compare molecular profiles with others genera of edible mushrooms, three species of Basidiomycetes (Pleurotus ostreatus, Lactarius deliciosus and Coriolus versicolor) and an Ascomycete were used. Results showed that some molecular markers discriminate among an Ascomycete from Basidiomycetes (Amanita ponderosa, Pleurotus ostreatus, Lactarius deliciosus and Coriolus versicolor) and discriminate among the different genera within basidiomycetes, as it is expected. Moreover, OPF-6, OPG-2, OPG3 and M13 primes allowed to unravel a level of genetic polymorphism within Amanita ponderosa mushrooms collected from different geographic origin.
Amanita ponderosa are wild edible mushrooms that grow only in some microclimates, particularly those in the southwestern part of the Iberian Peninsula. Due to the vast diversity of mushrooms in nature, as well as nutrient variability, which is highly dependent on soil type and environmental conditions, it is essential to be able to characterize fungal microbiota that lives in association with mushrooms and to differentiate A. ponderosa strains of different regions for certification purposes. In this study, we characterized the genetic profile of A. ponderosa mushrooms and the fungal strains that live in association with them in their natural habitat and compared the fingerprinting profiles obtained by M13-PCR amplification of the genomic DNA. We found that the predominant fungal isolates living in association with A. ponderosa were Aspergillus spp., Penicillium spp. and Mucor spp. M13-PCR molecular analysis showed that different fungal isolates had different genetic profiles. This approach allowed us to differentiate the different fungi strains isolated from fruiting bodies of A. ponderosa both rapidly and in a reproducible manner and to group them according to genus. Our fingerprinting analyses also distinguished different A. ponderosa mushrooms collected from different regions. Consequently, we conclude that this method is a very discriminatory approach for differentiating both A. ponderosa from different sites and the fungal microbiota that lives in association with these mushrooms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.